Pardes Biosciences Inc

NASDAQ:PRDS   3:59:52 PM EDT
3.42
-0.90 (-20.83%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Pardes Biosciences Inc Stock, NASDAQ:PRDS

2173 Salk Avenue, Suite 250, Carlsbad, California 92008
United States of America
Phone: +1.415.649.8758
Number of Employees:

Description

Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company. It develops oral antiviral drugs to treat and prevent various infections caused by coronavirus. The firm's product candidate, PBI-0451, is being developed as a potential direct-acting and oral antiviral drug to treat and prevent SARS-CoV-2 infections and associated diseases. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA.